Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.989 | 3 | 0 | 2002 | 2020 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.400 | None | 0.963 | 3 | 0 | 2002 | 2018 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
disease | 0.400 | None | 0.966 | 3 | 0 | 2002 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.400 | None | 0.946 | 3 | 0 | 1993 | 2019 | ||||||||
|
speckle type BTB/POZ protein | 0.597 | 0.500 | 1.00 |
|
disease | 0.700 | None | 0.957 | 3 | 1 | 2012 | 2020 | ||||||||
|
zinc finger homeobox 3 | 0.621 | 0.654 | 0.45 |
|
disease | 0.470 | None | 1.000 | 3 | 0 | 2005 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.970 | 3 | 0 | 1998 | 2020 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.400 | None | 0.905 | 3 | 0 | 2002 | 2018 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.989 | 3 | 0 | 2000 | 2019 | ||||||||
|
microseminoprotein beta | 0.498 | 0.846 | 1.6E-02 |
|
disease | 0.700 | None | 0.984 | 3 | 1 | 1993 | 2020 | ||||||||
|
ribonuclease L | 0.579 | 0.692 | 2.0E-10 |
|
disease | 0.500 | None | 0.871 | 3 | 0 | 2002 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.972 | 3 | 0 | 1994 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.400 | None | 0.815 | 3 | 0 | 2001 | 2020 | ||||||||
|
ETS variant transcription factor 1 | 0.631 | 0.385 | 0.94 |
|
disease | 0.400 | None | 0.962 | 3 | 0 | 2005 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.400 | None | 0.945 | 3 | 0 | 1992 | 2019 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1995 | 2019 | ||||||||
|
epoxide hydrolase 1 | 0.500 | 0.846 | 3.2E-09 |
|
disease | 0.340 | None | 0.800 | 3 | 0 | 2006 | 2014 | ||||||||
|
zinc finger MYM-type containing 3 | 0.760 | 0.308 | 1.00 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2014 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.400 | None | 0.875 | 3 | 0 | 1996 | 2019 | ||||||||
|
ezrin | 0.476 | 0.808 | 0.18 |
|
disease | 0.340 | None | 1.000 | 3 | 0 | 2004 | 2014 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.360 | None | 1.000 | 3 | 0 | 2003 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.887 | 3 | 0 | 1998 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.979 | 2 | 0 | 1998 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.944 | 2 | 1 | 2001 | 2019 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2018 | 2018 |